InvestorsHub Logo
Followers 231
Posts 38580
Boards Moderated 0
Alias Born 03/12/2015

Re: None

Wednesday, 07/29/2020 6:11:46 PM

Wednesday, July 29, 2020 6:11:46 PM

Post# of 186029
Let's give the company some credit. BLF and Pachyderm Labs are two good US businesses that the company managed to pull off along with GCC core. Anshu seems to be a highly dedicated CEO to make the business succeed. He is in a very tough OTC environment, driven by short term interest. Nobody wants to leave the company alone and give it a chance to succeed. Most of the board focus has nothing to do with the business, but rather how VRUS got their money to finance the operation. Well, as a company, they will do their best to get the best deal for the company with the current environment. So, what you see is the best deal they can get it. Live with it or leave it alone. Patchyderm products seem to be highly profitable. That should definitely improve their gross margin and make them profitable. According to CEO, details about the Patchyderm Labs will be revealed in Q3 filing due September 14, 2020.